Alfa Laval’s annual and sustainability report for 2024 published
LUND, Sweden, April 1, 2025 /PRNewswire/ — Alfa Laval’s annual and sustainability report for 2024 has today been published and can be downloaded from... Read more.
InteliChart Ranked #1 Patient Engagement Platform by Black Book Research for Third Consecutive Year
Nationwide, independent survey results reaffirm company’s impact on improving communication, engagement, and operational efficiency CHARLOTTE, N.C., April... Read more.
ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
LAUSANNE, Switzerland, April 1, 2025 /PRNewswire/ — ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will present... Read more.
ixlayer and Ipsos’ “ixInsights 2025” Study Reveals Consumer Expectations for Digital Health and Pharma’s Role in Enhancing Patient Experience
Study Captures Drivers and Deterrents to Digital Health to Inform Biopharma Cx, Commercialization and Marketing Efforts SAN FRANCISCO, April 1, 2025 /PRNewswire/... Read more.
Veeva Announces Research Site Clinical Trial Management System
Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsors PLEASANTON, Calif., April 1, 2025 /PRNewswire/ — Veeva Systems... Read more.
Meet vívoactive 6, the latest health and fitness smartwatch from Garmin
Know your body better with popular fitness, wellness and smart features—all on a bright, colorful display OLATHE, Kan., April 1, 2025 /PRNewswire/ — Garmin... Read more.
Informativ Recognized as One of the Fastest-Growing Private Companies in the Southwest by Inc. Magazine
Company’s rapid growth reflects growing demand for fraud and compliance technology solutions. FRISCO, Texas, April 1, 2025 /PRNewswire/ — Informativ,... Read more.
Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
MAHWAH, N.J., April 1, 2025 /PRNewswire/ — Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Vancomycin Hydrochloride for Injection USP,... Read more.
Scodix Announces Record-Breaking 2024: Achieves Profitability and 23% Revenue Growth, Driven by Groundbreaking Technology and Strategic Partnerships
ROSH HAAYIN, Israel, April 1, 2025 /PRNewswire/ — Scodix (TASE: SCDX) the pioneer and global leader in digital embellishment, today announced its financial... Read more.
Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia
DUBLIN, April 1, 2025 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced the initiation of Vibrance-3, a phase 2 clinical study evaluating the safety... Read more.